Activin Signaling Inhibitors Market Size, Share & Industry Analysis, By Drug Class (ActRII Ligand Traps/Fusion Proteins, Activin Receptor-Targeting Monoclonal Antibodies, and Others), By Indication (Hematologic Disorders, Cardiopulmonary Disorders, Muscle/Neuromuscular Disorders, Metabolic/Cardiometabolic disorders, and Others), By Age Group (Pediatric and Adults), By Route of Administration (Subcutaneous, Intravenous, and Others), By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Drug Stores & Retail Pharmacies, and Others), and Regional Forecast, 2026-2034